1306310-32-6 Usage
Uses
Used in Pharmaceutical Synthesis:
(trans)-2-methoxycyclopentan-1-amine is used as an intermediate in the synthesis of pharmaceuticals for its ability to participate in a range of chemical reactions and contribute to the development of new drugs.
Used in Agrochemical Synthesis:
In the agrochemical industry, (trans)-2-methoxycyclopentan-1-amine is used as a building block for the creation of various agrochemicals, such as pesticides and fertilizers, due to its unique structure and reactivity.
Used in Enantioselective Reactions:
As a ligand, (trans)-2-methoxycyclopentan-1-amine is used in metal-catalyzed enantioselective reactions to produce chiral compounds with high enantiomeric purity, which are essential in the pharmaceutical industry for the development of single-enantiomer drugs.
Used in the Preparation of Chiral Amino Alcohols:
(trans)-2-methoxycyclopentan-1-amine is also utilized in the preparation of chiral amino alcohols, which are important in various applications, including the synthesis of biologically active molecules and as catalysts in asymmetric synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 1306310-32-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,6,3,1 and 0 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1306310-32:
(9*1)+(8*3)+(7*0)+(6*6)+(5*3)+(4*1)+(3*0)+(2*3)+(1*2)=96
96 % 10 = 6
So 1306310-32-6 is a valid CAS Registry Number.
1306310-32-6Relevant articles and documents
FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF
-
Paragraph 0117; 0118, (2019/02/28)
The present invention relates to an FGFR4 inhibitor having a structure represented by formula (I), preparation method therefor, and applications thereof. A series of compounds represented by formula (I) in the present invention have a very-strong inhibiti
PHTHALAZINE DERIVATIVES, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
-
Paragraph 0168; 0172, (2018/11/21)
The present invention provides a compound of formula I, a cis-trans isomer, an enantiomer, a diastereoisomer, a racemate, a solvate, a hydrate, or a pharmaceutical acceptable salt and ester thereof, a preparation method for preparing the same, a pharmaceutical composition comprising the same and a use of the compound as an α5-GABAA receptor regulator, wherein T, Z, A and Y are as defined in the description.
